| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase inhibitor activity | 7.97e-06 | 13 | 62 | 3 | GO:0005095 | |
| GeneOntologyMolecularFunction | 11-beta-hydroxysteroid dehydrogenase [NAD(P)+] activity | 9.49e-06 | 2 | 62 | 2 | GO:0003845 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 1.61e-05 | 49 | 62 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | Krueppel-associated box domain binding | 2.84e-05 | 3 | 62 | 2 | GO:0035851 | |
| GeneOntologyMolecularFunction | protein decrotonylase activity | 9.43e-05 | 5 | 62 | 2 | GO:0160008 | |
| GeneOntologyMolecularFunction | histone decrotonylase activity | 9.43e-05 | 5 | 62 | 2 | GO:0160009 | |
| GeneOntologyMolecularFunction | acetylglucosaminyltransferase activity | 4.19e-04 | 47 | 62 | 3 | GO:0008375 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 4.37e-04 | 316 | 62 | 6 | GO:0035091 | |
| GeneOntologyMolecularFunction | actin filament binding | 6.94e-04 | 227 | 62 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | protein kinase A catalytic subunit binding | 1.11e-03 | 16 | 62 | 2 | GO:0034236 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.41e-03 | 18 | 62 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.13e-03 | 749 | 62 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | histone deacetylase activity | 2.51e-03 | 24 | 62 | 2 | GO:0004407 | |
| GeneOntologyMolecularFunction | protein kinase activity | 2.51e-03 | 600 | 62 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | protein lysine deacetylase activity | 2.72e-03 | 25 | 62 | 2 | GO:0033558 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC35D1 PIEZO2 SLC15A2 SLC16A2 SLC22A5 ANO1 TRPV6 SLC33A1 RYR2 ITPR2 | 3.24e-03 | 1180 | 62 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | lipid binding | IQGAP2 SBF2 ANXA8L1 ANXA8 TMEM97 HSD11B1 HSD11B2 IQGAP1 ITPR2 | 3.28e-03 | 988 | 62 | 9 | GO:0008289 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 3.40e-03 | 199 | 62 | 4 | GO:1901981 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | IPO5 JAK2 STAC2 MGAT3 CSNK2A2 ANO1 TMEM97 ITGB2 GSK3A IQGAP1 | 9.72e-06 | 591 | 62 | 10 | GO:1903829 |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 2.66e-05 | 3 | 62 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 2.66e-05 | 3 | 62 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 2.66e-05 | 3 | 62 | 2 | GO:1902407 | |
| GeneOntologyBiologicalProcess | negative regulation of phospholipase A2 activity | 2.66e-05 | 3 | 62 | 2 | GO:1900138 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 5.31e-05 | 4 | 62 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | fungiform papilla formation | 5.31e-05 | 4 | 62 | 2 | GO:0061198 | |
| GeneOntologyBiologicalProcess | negative regulation of phospholipase activity | 8.84e-05 | 5 | 62 | 2 | GO:0010519 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 8.94e-05 | 29 | 62 | 3 | GO:0042659 | |
| GeneOntologyBiologicalProcess | positive regulation of signaling receptor activity | 1.32e-04 | 33 | 62 | 3 | GO:2000273 | |
| GeneOntologyBiologicalProcess | fungiform papilla morphogenesis | 1.32e-04 | 6 | 62 | 2 | GO:0061197 | |
| GeneOntologyBiologicalProcess | hair follicle placode formation | 1.32e-04 | 6 | 62 | 2 | GO:0060789 | |
| GeneOntologyBiologicalProcess | response to interleukin-3 | 1.85e-04 | 7 | 62 | 2 | GO:0036015 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-3 | 1.85e-04 | 7 | 62 | 2 | GO:0036016 | |
| GeneOntologyBiologicalProcess | fungiform papilla development | 1.85e-04 | 7 | 62 | 2 | GO:0061196 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 2.01e-04 | 403 | 62 | 7 | GO:1904951 | |
| GeneOntologyBiologicalProcess | negative regulation of serine-type peptidase activity | 2.46e-04 | 8 | 62 | 2 | GO:1902572 | |
| GeneOntologyBiologicalProcess | negative regulation of serine-type endopeptidase activity | 2.46e-04 | 8 | 62 | 2 | GO:1900004 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 3.16e-04 | 9 | 62 | 2 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 3.16e-04 | 9 | 62 | 2 | GO:0000912 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 3.52e-04 | 442 | 62 | 7 | GO:0050878 | |
| GeneOntologyBiologicalProcess | regulation of serine-type peptidase activity | 3.94e-04 | 10 | 62 | 2 | GO:1902571 | |
| GeneOntologyBiologicalProcess | regulation of phospholipase A2 activity | 3.94e-04 | 10 | 62 | 2 | GO:0032429 | |
| GeneOntologyBiologicalProcess | regulation of serine-type endopeptidase activity | 3.94e-04 | 10 | 62 | 2 | GO:1900003 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring organization | 3.94e-04 | 10 | 62 | 2 | GO:0044837 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 4.99e-04 | 122 | 62 | 4 | GO:0055013 | |
| GeneOntologyBiologicalProcess | regulation of cell fate commitment | 5.44e-04 | 53 | 62 | 3 | GO:0010453 | |
| GeneOntologyBiologicalProcess | tongue morphogenesis | 5.75e-04 | 12 | 62 | 2 | GO:0043587 | |
| GeneOntologyBiologicalProcess | negative regulation of glycogen biosynthetic process | 5.75e-04 | 12 | 62 | 2 | GO:0045719 | |
| GeneOntologyBiologicalProcess | negative regulation of protein catabolic process | 6.52e-04 | 131 | 62 | 4 | GO:0042177 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 6.71e-04 | 132 | 62 | 4 | GO:0055006 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SLC35D1 OR8K1 MOGAT1 CAMLG COPB2 SEC11C TMEM97 ERMP1 EXTL3 HSD11B1 HSD11B2 SLC33A1 RYR2 ITPR2 | 1.97e-05 | 1293 | 62 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SLC35D1 OR8K1 MOGAT1 CAMLG COPB2 SEC11C TMEM97 ERMP1 EXTL3 HSD11B1 HSD11B2 SLC33A1 RYR2 ITPR2 | 2.08e-05 | 1299 | 62 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | SLC35D1 OR8K1 MOGAT1 CAMLG COPB2 SEC11C TMEM97 ERMP1 EXTL3 HSD11B1 HSD11B2 SLC33A1 RYR2 ITPR2 | 2.63e-05 | 1327 | 62 | 14 | GO:0042175 |
| GeneOntologyCellularComponent | PcG protein complex | 4.95e-04 | 52 | 62 | 3 | GO:0031519 | |
| GeneOntologyCellularComponent | CHD-type complex | 1.14e-03 | 17 | 62 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 1.14e-03 | 17 | 62 | 2 | GO:0016581 | |
| Domain | AnnexinVIII | 1.05e-05 | 2 | 61 | 2 | IPR009115 | |
| Domain | RasGAP_C | 3.14e-05 | 3 | 61 | 2 | IPR000593 | |
| Domain | RasGAP_C | 3.14e-05 | 3 | 61 | 2 | PF03836 | |
| Domain | His_deacetylse_1 | 6.27e-05 | 4 | 61 | 2 | IPR003084 | |
| Domain | RIH_assoc | 1.56e-04 | 6 | 61 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.56e-04 | 6 | 61 | 2 | IPR013662 | |
| Domain | RIH_dom | 1.56e-04 | 6 | 61 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.56e-04 | 6 | 61 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.56e-04 | 6 | 61 | 2 | IPR015925 | |
| Domain | - | 1.56e-04 | 6 | 61 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.56e-04 | 6 | 61 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 1.56e-04 | 6 | 61 | 2 | PF08709 | |
| Domain | MIR | 4.64e-04 | 10 | 61 | 2 | PS50919 | |
| Domain | MIR | 4.64e-04 | 10 | 61 | 2 | PF02815 | |
| Domain | MIR | 4.64e-04 | 10 | 61 | 2 | SM00472 | |
| Domain | MIR_motif | 4.64e-04 | 10 | 61 | 2 | IPR016093 | |
| Domain | Hist_deacetyl | 5.66e-04 | 11 | 61 | 2 | PF00850 | |
| Domain | His_deacetylse_dom | 5.66e-04 | 11 | 61 | 2 | IPR023801 | |
| Domain | - | 5.66e-04 | 11 | 61 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse | 5.66e-04 | 11 | 61 | 2 | IPR000286 | |
| Domain | PROTEIN_KINASE_ATP | 7.18e-04 | 459 | 61 | 7 | PS00107 | |
| Domain | ANX | 8.00e-04 | 13 | 61 | 2 | SM00335 | |
| Domain | ANNEXIN | 8.00e-04 | 13 | 61 | 2 | PS00223 | |
| Domain | Annexin_repeat_CS | 8.00e-04 | 13 | 61 | 2 | IPR018252 | |
| Domain | Annexin | 8.00e-04 | 13 | 61 | 2 | PF00191 | |
| Domain | Annexin_repeat | 8.00e-04 | 13 | 61 | 2 | IPR018502 | |
| Domain | - | 8.00e-04 | 13 | 61 | 2 | 1.10.220.10 | |
| Domain | Annexin | 9.31e-04 | 14 | 61 | 2 | IPR001464 | |
| Domain | RasGAP | 9.31e-04 | 14 | 61 | 2 | SM00323 | |
| Domain | RasGAP_CS | 9.31e-04 | 14 | 61 | 2 | IPR023152 | |
| Domain | MFS_dom | 9.63e-04 | 134 | 61 | 4 | IPR020846 | |
| Domain | Prot_kinase_dom | 1.04e-03 | 489 | 61 | 7 | IPR000719 | |
| Domain | RasGAP | 1.07e-03 | 15 | 61 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 1.07e-03 | 15 | 61 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 1.07e-03 | 15 | 61 | 2 | PS50018 | |
| Domain | PROTEIN_KINASE_DOM | 1.09e-03 | 493 | 61 | 7 | PS50011 | |
| Domain | - | 1.22e-03 | 16 | 61 | 2 | 1.10.506.10 | |
| Domain | Protein_kinase_ATP_BS | 1.45e-03 | 379 | 61 | 6 | IPR017441 | |
| Domain | RasGAP_dom | 1.55e-03 | 18 | 61 | 2 | IPR001936 | |
| Domain | IQ | 1.62e-03 | 71 | 61 | 3 | PF00612 | |
| Domain | Kinase-like_dom | 1.87e-03 | 542 | 61 | 7 | IPR011009 | |
| Domain | IQ | 2.36e-03 | 81 | 61 | 3 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 3.18e-03 | 90 | 61 | 3 | IPR000048 | |
| Domain | IQ | 3.49e-03 | 93 | 61 | 3 | PS50096 | |
| Domain | Sc_DH/Rdtase_CS | 5.83e-03 | 35 | 61 | 2 | IPR020904 | |
| Domain | Ser/Thr_kinase_AS | 6.15e-03 | 357 | 61 | 5 | IPR008271 | |
| Domain | Ion_trans_dom | 6.16e-03 | 114 | 61 | 3 | IPR005821 | |
| Domain | Ion_trans | 6.16e-03 | 114 | 61 | 3 | PF00520 | |
| Domain | PROTEIN_KINASE_ST | 6.51e-03 | 362 | 61 | 5 | PS00108 | |
| Domain | Pkinase | 8.04e-03 | 381 | 61 | 5 | PF00069 | |
| Domain | Pkinase_Tyr | 8.65e-03 | 129 | 61 | 3 | PF07714 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 4.31e-06 | 32 | 49 | 4 | MM15850 | |
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 12082111 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | JAK2 BMPR1A CSNK2A2 IRAK3 MERTK MAPK7 NFS1 GSK3A HDAC1 HDAC2 ITPR2 | 5.57e-07 | 910 | 62 | 11 | 36736316 |
| Pubmed | PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. | 8.82e-07 | 41 | 62 | 4 | 22325352 | |
| Pubmed | 2.00e-06 | 329 | 62 | 7 | 17474147 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 35575026 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23792463 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23362866 | ||
| Pubmed | Glucocorticoid synthesis-related genes: HSD11B1 and HSD11B2 in hypertensive disorders in pregnancy. | 3.13e-06 | 2 | 62 | 2 | 23659736 | |
| Pubmed | Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts. | 3.13e-06 | 2 | 62 | 2 | 19531758 | |
| Pubmed | 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. | 3.13e-06 | 2 | 62 | 2 | 9034789 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 1364010 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 16406280 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 21763800 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 31222845 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24769558 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24998570 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24525021 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 11287668 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 7670488 | ||
| Pubmed | Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. | 3.13e-06 | 2 | 62 | 2 | 18388900 | |
| Pubmed | CK2.1, a novel peptide, induces articular cartilage formation in vivo. | 3.13e-06 | 2 | 62 | 2 | 27312334 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 31533525 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24054540 | ||
| Pubmed | IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. | 3.13e-06 | 2 | 62 | 2 | 20977743 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 34890513 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 32366868 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 21423190 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 25380525 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24335310 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 19542242 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 38523117 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 25788665 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 18408217 | ||
| Pubmed | Cooperative binding promotes demand-driven recruitment of AnxA8 to cholesterol-containing membranes. | 3.13e-06 | 2 | 62 | 2 | 29306076 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28579617 | ||
| Pubmed | HDAC1 and HDAC2 Modulate TGF-β Signaling during Endothelial-to-Hematopoietic Transition. | 3.13e-06 | 2 | 62 | 2 | 29641990 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24040068 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 26174178 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 25270209 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22156779 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28158491 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 11733403 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 32145408 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 30902677 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23251689 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22719058 | ||
| Pubmed | Expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer. | 3.13e-06 | 2 | 62 | 2 | 15172126 | |
| Pubmed | Histone deacetylase HDA-1 modulates mitochondrial stress response and longevity. | 3.13e-06 | 2 | 62 | 2 | 32934238 | |
| Pubmed | IQGAP1 protein regulates nuclear localization of β-catenin via importin-β5 protein in Wnt signaling. | 3.13e-06 | 2 | 62 | 2 | 24196961 | |
| Pubmed | Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. | 3.13e-06 | 2 | 62 | 2 | 20802485 | |
| Pubmed | Bone matrix regulates osteoclast differentiation and annexin A8 gene expression. | 3.13e-06 | 2 | 62 | 2 | 21344395 | |
| Pubmed | Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing. | 3.13e-06 | 2 | 62 | 2 | 31799598 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 15016876 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 11919195 | ||
| Pubmed | Dysregulation of 11beta-hydroxysteroid dehydrogenases: implications during pregnancy and beyond. | 3.13e-06 | 2 | 62 | 2 | 27018008 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 21292776 | ||
| Pubmed | Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. | 3.13e-06 | 2 | 62 | 2 | 18180285 | |
| Pubmed | Genetic dissection of histone deacetylase requirement in tumor cells. | 3.13e-06 | 2 | 62 | 2 | 19416910 | |
| Pubmed | Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma. | 3.13e-06 | 2 | 62 | 2 | 24149070 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24810847 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23287868 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 12109593 | ||
| Pubmed | HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells. | 3.13e-06 | 2 | 62 | 2 | 31071955 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 11165006 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 16203777 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24729284 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 25942572 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 18573267 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 19553468 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24449838 | ||
| Pubmed | HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells. | 3.13e-06 | 2 | 62 | 2 | 20398369 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 15928709 | ||
| Pubmed | Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice. | 3.13e-06 | 2 | 62 | 2 | 22307625 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 26116233 | ||
| Pubmed | Effect of cellular differentiation on 11beta-hydroxysteroid dehydrogenase activity in the intestine. | 3.13e-06 | 2 | 62 | 2 | 11755176 | |
| Pubmed | Dynamic distribution of HDAC1 and HDAC2 during mitosis: association with F-actin. | 3.13e-06 | 2 | 62 | 2 | 23280436 | |
| Pubmed | Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL. | 3.13e-06 | 2 | 62 | 2 | 25688158 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23516383 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 19740981 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 10904264 | ||
| Pubmed | HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis. | 3.13e-06 | 2 | 62 | 2 | 25648995 | |
| Pubmed | Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. | 3.13e-06 | 2 | 62 | 2 | 17639084 | |
| Pubmed | 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. | 3.13e-06 | 2 | 62 | 2 | 15466942 | |
| Pubmed | Mitochondrial calcium overload is a key determinant in heart failure. | 3.13e-06 | 2 | 62 | 2 | 26217001 | |
| Pubmed | Differential HDAC1/2 network analysis reveals a role for prefoldin/CCT in HDAC1/2 complex assembly. | 3.13e-06 | 2 | 62 | 2 | 30209338 | |
| Pubmed | HDAC1 and HDAC2 are differentially expressed in endometriosis. | 3.13e-06 | 2 | 62 | 2 | 22344732 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17519316 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24147632 | ||
| Pubmed | HDAC1 and HDAC2 independently regulate common and specific intrinsic responses in murine enteroids. | 3.13e-06 | 2 | 62 | 2 | 30926862 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 11956655 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 11917092 | ||
| Pubmed | Trans-regulation of histone deacetylase activities through acetylation. | 3.13e-06 | 2 | 62 | 2 | 19822520 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 19022342 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 31692265 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 15297431 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24958871 | ||
| Pubmed | Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer. | 3.13e-06 | 2 | 62 | 2 | 20585871 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 26129908 | ||
| Pubmed | Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. | 3.13e-06 | 2 | 62 | 2 | 19412887 | |
| Pubmed | Function, gene organization and protein structures of 11beta-hydroxysteroid dehydrogenase isoforms. | 3.13e-06 | 2 | 62 | 2 | 9370340 | |
| Cytoband | 9p24 | 5.00e-05 | 8 | 62 | 2 | 9p24 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 3.31e-05 | 4 | 43 | 2 | 989 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.97e-04 | 9 | 43 | 2 | 1306 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 3.59e-04 | 12 | 43 | 2 | 1243 | |
| GeneFamily | PHD finger proteins|NuRD complex | 3.59e-04 | 12 | 43 | 2 | 1305 | |
| GeneFamily | Annexins|Endogenous ligands | 4.24e-04 | 13 | 43 | 2 | 404 | |
| GeneFamily | Solute carriers | 2.36e-03 | 395 | 43 | 5 | 752 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP | 1.10e-06 | 33 | 62 | 4 | M41050 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_DN | 9.60e-06 | 207 | 62 | 6 | MM988 | |
| Coexpression | MCCLUNG_COCAIN_REWARD_4WK | 2.88e-05 | 74 | 62 | 4 | M1600 | |
| Coexpression | MCCLUNG_COCAIN_REWARD_4WK | 3.20e-05 | 76 | 62 | 4 | MM682 | |
| Coexpression | ROSS_AML_WITH_PML_RARA_FUSION | 3.92e-05 | 80 | 62 | 4 | M15368 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP | 7.36e-05 | 183 | 62 | 5 | M12621 | |
| Coexpression | GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP | 9.93e-05 | 195 | 62 | 5 | M8140 | |
| Coexpression | GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP | 1.09e-04 | 199 | 62 | 5 | M5365 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.09e-04 | 199 | 62 | 5 | M9179 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN | 1.12e-04 | 200 | 62 | 5 | M4560 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_DN | 1.17e-04 | 202 | 62 | 5 | M12428 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-07 | 177 | 61 | 6 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-07 | 177 | 61 | 6 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 159 | 61 | 5 | 709b57f992a29878cc899d760d144d36cb5cb280 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-06 | 177 | 61 | 5 | 6d89042bda8e244babb68929e84b25edcb545a77 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-06 | 177 | 61 | 5 | daaccf1249dcf816df4caca695a944f53078291a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-06 | 177 | 61 | 5 | 338bdda26796bf4e16072878c070212d1006cf57 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-06 | 177 | 61 | 5 | c5a16f984c836dbf7d0faf061677844167ab612a | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.81e-06 | 180 | 61 | 5 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-06 | 181 | 61 | 5 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-06 | 181 | 61 | 5 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-06 | 181 | 61 | 5 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-06 | 181 | 61 | 5 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 7.10e-06 | 195 | 61 | 5 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.46e-06 | 197 | 61 | 5 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 140 | 61 | 4 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.77e-05 | 153 | 61 | 4 | 489228ab81c3ae339a53a9da6c2a1c1b6ac3f84b | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.77e-05 | 153 | 61 | 4 | 95b28c5bd10ffb74c0993ebd565038b9818e4bd2 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.77e-05 | 153 | 61 | 4 | b09f8def40a1ea56722f3398f61a036667b61cd9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.77e-05 | 153 | 61 | 4 | 3ab9d55b3db51715c1d61eca142384195ce4b54f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-05 | 155 | 61 | 4 | 51f6447945389649d99dcf7603b396195c631ead | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-05 | 155 | 61 | 4 | 23dc71cab28094ca0ac4d2baf4e24871ed107781 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 6.22e-05 | 156 | 61 | 4 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 156 | 61 | 4 | a4b0e89255ea5d60198cb2b3e739981f9c9cf5c5 | |
| ToppCell | IPF-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 6.54e-05 | 158 | 61 | 4 | 67adf625a959444762d32268b3b7441f6f8b3b8c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 7.38e-05 | 163 | 61 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | lung-Club_Cells|lung / shred on tissue and cell subclass | 7.55e-05 | 164 | 61 | 4 | b12cacd499b18b96120ca6d14646aebeaed41d10 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 169 | 61 | 4 | 2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 169 | 61 | 4 | 4b3a7b4a497178799b6b2f0b744f5fb752cee31a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 169 | 61 | 4 | a4fd646b9bf87225131fca530bd6b52df9eaf489 | |
| ToppCell | control-Myeloid-Eosinophils|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.88e-05 | 171 | 61 | 4 | 82f736c33ed96c0865618e8f8eb82a5487126bdc | |
| ToppCell | Influenza_Severe-B_intermediate|World / Disease group and Cell class | 8.88e-05 | 171 | 61 | 4 | 4d33e1dc1efc423dbdd5f4cca6d6440a68add8d0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-05 | 173 | 61 | 4 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.50e-05 | 174 | 61 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-05 | 176 | 61 | 4 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 178 | 61 | 4 | 3d6d03bc57062f74ba19fc675dd36b12b6c7115d | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.13e-04 | 182 | 61 | 4 | 6e7dac78dc030f74e546b9f6db07556e9bb13ac2 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.13e-04 | 182 | 61 | 4 | cd972d30519db706477c6b0c901165b81b74abed | |
| ToppCell | control-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.18e-04 | 184 | 61 | 4 | fad517d047e8eaeaa5bd4f311d770880568dd13c | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 1.18e-04 | 184 | 61 | 4 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 1.23e-04 | 186 | 61 | 4 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.25e-04 | 187 | 61 | 4 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 188 | 61 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | AT1-AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-04 | 188 | 61 | 4 | be710bc957118cf426dd71c2d57e6f1b41c9a467 | |
| ToppCell | ASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.31e-04 | 189 | 61 | 4 | 316c857dec9383823e09f966bca62d52d933b141 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 189 | 61 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.31e-04 | 189 | 61 | 4 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 1.31e-04 | 189 | 61 | 4 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 190 | 61 | 4 | cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 192 | 61 | 4 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 192 | 61 | 4 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.41e-04 | 193 | 61 | 4 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 193 | 61 | 4 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 196 | 61 | 4 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 1.50e-04 | 196 | 61 | 4 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 1.50e-04 | 196 | 61 | 4 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.50e-04 | 196 | 61 | 4 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 196 | 61 | 4 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.53e-04 | 197 | 61 | 4 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.53e-04 | 197 | 61 | 4 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.53e-04 | 197 | 61 | 4 | 6f41c8f815851968849428ec92c16745bd01a3fb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.53e-04 | 197 | 61 | 4 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.53e-04 | 197 | 61 | 4 | 304044ace926943b8eb588f686ecbe5d1689a809 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 1.56e-04 | 198 | 61 | 4 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.56e-04 | 198 | 61 | 4 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | distal-1-mesenchymal-Alveolar_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 198 | 61 | 4 | 6594c35ab203dc51462167c61807b0d49fa30fb2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.56e-04 | 198 | 61 | 4 | 641e7be258303bb9782d19fcf8693f317581d3b8 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.59e-04 | 199 | 61 | 4 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-04 | 199 | 61 | 4 | a4785c1921a3de18a9190e4d674ede6a90f80004 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.59e-04 | 199 | 61 | 4 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.59e-04 | 199 | 61 | 4 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.62e-04 | 200 | 61 | 4 | 7c56935446f10d202eafa1f9ee7cb0aae4c2607e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-04 | 200 | 61 | 4 | 401d50fa394fa863fa7836344110ae5c7af3250a | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.62e-04 | 200 | 61 | 4 | 33c5615cbedb9e14f4433169babd3a3a51f69b4c | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.62e-04 | 200 | 61 | 4 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | mLN-(6)_Macrophage-(61)_LYVE1_Macrophage|mLN / shred on region, Cell_type, and subtype | 1.62e-04 | 200 | 61 | 4 | a20f5ec61d492d8a2adf695ec304b5d57296aa8f | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|mLN / Region, Cell class and subclass | 1.62e-04 | 200 | 61 | 4 | 89cf739a3c2f5d30e547404f2f2ec6500cd1d65d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-04 | 200 | 61 | 4 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-04 | 200 | 61 | 4 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.62e-04 | 200 | 61 | 4 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-04 | 200 | 61 | 4 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-04 | 200 | 61 | 4 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | distal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.62e-04 | 200 | 61 | 4 | 20112be28f80baffad92641c9cfd7c3718967dbb | |
| Drug | D3 F | 7.06e-06 | 2 | 61 | 2 | CID002799606 | |
| Drug | 20beta-dihydrocortisol | 7.06e-06 | 2 | 61 | 2 | CID000165046 | |
| Drug | 7 beta-hydroxysteroid | 7.06e-06 | 2 | 61 | 2 | CID000439865 | |
| Drug | valproate | 7.76e-06 | 381 | 61 | 8 | CID000003121 | |
| Drug | Caffeine | MOGAT1 CSNK2A2 TMEM97 HSD11B1 HSD11B2 GSK3A RYR2 HDAC1 HDAC2 | 8.81e-06 | 515 | 61 | 9 | ctd:D002110 |
| Drug | angiotensin | 1.02e-05 | 282 | 61 | 7 | CID003083715 | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.50e-05 | 198 | 61 | 6 | 3756_DN | |
| Drug | 11-dehydrocorticosterone | 2.11e-05 | 3 | 61 | 2 | ctd:C003552 | |
| Drug | FK037 | 2.11e-05 | 3 | 61 | 2 | CID009570998 | |
| Drug | AC1NB5VE | 2.11e-05 | 3 | 61 | 2 | CID004487903 | |
| Drug | diethylcarbamate | 4.22e-05 | 4 | 61 | 2 | CID003757586 | |
| Drug | 2'-hydroxyflavone | 7.02e-05 | 5 | 61 | 2 | CID000161860 | |
| Drug | AC1Q6O8R | 7.02e-05 | 5 | 61 | 2 | CID000009791 | |
| Drug | Vorinostat | 7.02e-05 | 5 | 61 | 2 | DB02546 | |
| Drug | 6 beta-hydroxyprednisolone | 7.02e-05 | 5 | 61 | 2 | CID000152139 | |
| Disease | trimethylamine-N-oxide measurement | 2.86e-06 | 14 | 60 | 3 | EFO_0010541 | |
| Disease | Pregnancy Complications | 1.22e-05 | 3 | 60 | 2 | C0032962 | |
| Disease | Brain Tumor, Primary | 4.18e-05 | 33 | 60 | 3 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 4.18e-05 | 33 | 60 | 3 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 4.18e-05 | 33 | 60 | 3 | C0750977 | |
| Disease | Neoplasms, Intracranial | 4.18e-05 | 33 | 60 | 3 | C1527390 | |
| Disease | Benign neoplasm of brain, unspecified | 4.18e-05 | 33 | 60 | 3 | C0496899 | |
| Disease | Malignant neoplasm of brain | 6.41e-05 | 38 | 60 | 3 | C0153633 | |
| Disease | Brain Neoplasms | 6.93e-05 | 39 | 60 | 3 | C0006118 | |
| Disease | alopecia areata (is_marker_for) | 1.81e-04 | 10 | 60 | 2 | DOID:986 (is_marker_for) | |
| Disease | Thromboembolism | 2.65e-04 | 12 | 60 | 2 | C0040038 | |
| Disease | smooth surface dental caries | 2.78e-04 | 62 | 60 | 3 | EFO_0006339 | |
| Disease | pulmonary hypertension (is_marker_for) | 3.05e-04 | 64 | 60 | 3 | DOID:6432 (is_marker_for) | |
| Disease | inherited metabolic disorder (is_implicated_in) | 4.20e-04 | 15 | 60 | 2 | DOID:655 (is_implicated_in) | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 4.31e-04 | 72 | 60 | 3 | DOID:9744 (is_marker_for) | |
| Disease | partial epilepsy | 5.42e-04 | 17 | 60 | 2 | EFO_0004263 | |
| Disease | Tachyarrhythmia | 6.09e-04 | 18 | 60 | 2 | C0080203 | |
| Disease | Tachycardia | 6.09e-04 | 18 | 60 | 2 | C0039231 | |
| Disease | Cardiac Arrhythmia | 1.18e-03 | 25 | 60 | 2 | C0003811 | |
| Disease | Heart valve disease | 1.28e-03 | 26 | 60 | 2 | C0018824 | |
| Disease | birth weight | 1.31e-03 | 399 | 60 | 5 | EFO_0004344 | |
| Disease | Crohn's disease (is_implicated_in) | 1.71e-03 | 30 | 60 | 2 | DOID:8778 (is_implicated_in) | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 1.94e-03 | 32 | 60 | 2 | DOID:332 (is_implicated_in) | |
| Disease | asthma, Eczema, allergic rhinitis | 1.94e-03 | 121 | 60 | 3 | EFO_0005854, HP_0000964, MONDO_0004979 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPFLCLYYPQMLYIK | 261 | A0A0G2JMD5 | |
| FYKAMPYRLLLGLEY | 376 | O00400 | |
| LNLVMYPKLGYVIYS | 276 | Q96KX2 | |
| PFLTLQLAYMGLYKY | 216 | P49069 | |
| MYLLGYIPKDNRLYL | 561 | P35606 | |
| RRKYFYLVGYGMPAL | 966 | Q9HAR2 | |
| LLIYMDYPRYLGAVF | 276 | Q8TC27 | |
| KYLLPILGLFMAYYY | 6 | P28845 | |
| LMYFIHYYLPEGLRR | 346 | P80365 | |
| IAFYLLGMFIPYLYA | 581 | Q7Z2K6 | |
| PLLAIGFYLYRMNKY | 416 | A8MX76 | |
| IIGNLLYYRYMNPAI | 1186 | P46940 | |
| AALGYFVPYVHLMKY | 331 | P36021 | |
| KLIMEYLPYGSLRDY | 926 | O60674 | |
| LGDQRYAPYKYMLRL | 541 | Q14571 | |
| LIVALMYPPYRYEAK | 86 | P13928 | |
| MLIIHNYLFLYIPYL | 41 | Q96PD6 | |
| YFLYQLLRGLKYMHS | 161 | Q13164 | |
| FLPMYGLYEYLRKSV | 566 | O95461 | |
| PRVLDAMLPYLINYY | 71 | Q9Y697 | |
| NYLVFLLMYLFPRQL | 151 | Q6P1Q0 | |
| MYAPKYLLKNYDRFH | 481 | Q09327 | |
| LPFMKYGDLHTYLLY | 671 | Q12866 | |
| LLLNYGLYRKMEIYR | 41 | Q13547 | |
| LESLMFPLKYSYPYI | 241 | Q86WG5 | |
| DPRDYKLLDMLQYYL | 341 | Q92484 | |
| FIPRLVYLYMYSKNG | 811 | Q5XXA6 | |
| KFCLIYPYMRNGTLF | 236 | Q9Y616 | |
| LFYGSIIFMYLQPAK | 251 | Q8N628 | |
| KYAEYFLRPMLQYVC | 901 | O00410 | |
| RAKGYPIDLYYLMDL | 121 | P05107 | |
| IPILYVKVYMYQLFR | 216 | P49840 | |
| YYCPELRQKAYMFIL | 151 | Q6JEL2 | |
| LIVALMYPPYRYEAK | 86 | Q5VT79 | |
| YSQMLLFPYGYTSKL | 306 | P15088 | |
| PLGRDQYKEMYLFVY | 91 | Q92874 | |
| NFFVKVYGYMPLLYT | 881 | O43909 | |
| MPQLYIYIRLLGAYL | 1 | P36894 | |
| FYIPFLLMVLAYYRI | 201 | Q13639 | |
| RYFKGPELLVDYQMY | 196 | P19784 | |
| DLQPYKYAGYPMLIR | 1386 | O75165 | |
| YKNSMGKSLPLFYIY | 256 | Q5VSG8 | |
| LLKYGMLLYQNYRIP | 396 | Q13322 | |
| NLLLNYGLYRKMEIY | 41 | Q92769 | |
| YGMKAVLILYFLYFL | 61 | Q16348 | |
| VYLGAYDRFLPYILM | 481 | O76082 | |
| NKYMPGLLRAGYYDL | 1691 | Q92736 | |
| YPKFKYALLAVMGAY | 171 | Q9BY50 | |
| YYYMLPMKVRALGLK | 161 | Q9BYD3 | |
| GYVYIPLAFLLMLYA | 111 | Q8IW70 | |
| LLKIVGNLLYYRYMN | 1096 | Q13576 | |
| MFYGTLLFIYLQPKS | 256 | Q8NGG5 | |
| KYGLLYYNALFMILP | 216 | Q9NTN3 | |
| LILSLVYYFYNLMPL | 751 | Q8NBP0 | |
| YMGLKLGPALKLCYY | 676 | Q9UQR0 | |
| VGPMYSYVALYKFLP | 291 | Q6ZMT1 | |
| YVGQPRFLLLFYAMY | 1901 | Q9H5I5 | |
| RPYFCMLGAIYLLYI | 366 | Q9H1D0 | |
| SPFLCLYYPQMLYIK | 261 | O60809 | |
| ILLIFMLRSPYYKYE | 156 | Q5BJF2 | |
| RHYYFLGRMLGKALY | 816 | Q15386 | |
| GMALYKIVPKNPYYF | 136 | Q14CX7 |